查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595361

色素失调治疗市场：按适应症、治疗方法、最终用户划分 - 2025-2030 年全球预测

Pigmentation Disorders Treatment Market by Indication (Hyperpigmentation, Hypopigmentation), Treatment & Therapies (Chemical Peels, Dermabrasion, Laser Resurfacing), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年色素障碍治疗市值为67.8亿美元，预计2024年将达到72.8亿美元，复合年增长率为7.42%，到2030年将达到112.1亿美元。

色素失调治疗市场包括旨在纠正因黑色素生成过多、荷尔蒙失衡和遗传条件等因素引起的肤色异常的治疗方法和解决方案。由于人们对美丽肌肤的需求不断增加，以及黄褐斑、白斑症和色素沉着等色素沉着疾病的日益流行，这个市场的需求庞大。应用包括局部药膏、雷射治疗、化学换肤和药物干预，主要由皮肤科医生和美容诊所使用。最终用途范围涵盖医疗设施和专注于美容和健康的直接面向消费者的护肤品牌。

主要市场统计
基准年[2023] 67.8亿美元
预测年份 [2024] 72.8亿美元
预测年份 [2030] 112.1亿美元
复合年增长率（%） 7.42%

市场成长是由皮肤病学技术的进步和消费者对皮肤健康意识的提高所推动的。新兴国家可支配收入的增加和对自我护理的日益偏好导致更多的治疗方案被采用。此外，开拓更有效、侵入性更小的治疗方法代表了市场扩张的重大机会。然而，高昂的费用、缺乏全民保险覆盖以及先进治疗的潜在副作用等限制带来了挑战。此外，市场分散，产品供应和患者获得治疗的机会存在地区差异。

为了利用成长机会，我们需要投资下一代治疗方法，以最大限度地减少副作用并更快地获得结果，例如基因疗法和生物工程皮肤治疗。加强对个人化和种族定制治疗方法的研究也将推动市场主导。这个市场的本质是竞争性的，其特点是不断的技术创新、监管监督和快速的技术进步。有效的市场策略应着重策略联盟、併购，以加强研发能力。针对年轻人的创新行销和数位健康平台的使用也有可能提高消费者参与度并扩大市场覆盖范围。

市场动态：快速发展的色素紊乱治疗市场的关键市场洞察

供需的动态交互作用正在改变色素障碍治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 人们对护肤重要性的认识和兴趣不断增强
    • 化妆品和护肤品支出增加
    • 研发费用增加和积极的营销策略
  • 市场限制因素
    • 治疗费用上涨和治疗结果差异
  • 市场机会
    • 雷射治疗和针刺工艺等技术的进步
    • 壬二酸等多种药物的进展
  • 市场挑战
    • 皮肤敏感增加、过敏、对某些药物的反应

波特的五力：驾驭色素紊乱治疗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解色素紊乱治疗市场的外部影响

外部宏观环境因素在塑造色素障碍治疗市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解色素障碍治疗市场的竞争状况

对色素紊乱治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位基质色素紊乱治疗市场供应商的绩效评估

FPNV定位矩阵是评估色素障碍治疗市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了色素障碍治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，色素紊乱治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人们对护肤重要性的认识和兴趣不断增强
      • 化妆品和护肤品支出增加
      • 研发费用增加和积极的营销策略
    • 抑制因素
      • 治疗费用高且结果各异。
    • 机会
      • 雷射治疗和针刺工艺等技术进步
      • 壬二酸等多种药物的进展
    • 任务
      • 皮肤敏感、过敏和对某些物质的反应增加
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依适应症分類的色素失调治疗市场

  • 色素沉着
  • 色素沉淀不足

第七章色素紊乱治疗市场治疗与疗法

  • 化学换肤
  • 皮肤脱皮
  • 表面置换
  • 黄褐斑

第八章色素失调治疗市场：依最终使用者分类

  • 皮肤科诊所
  • 医院

第九章北美与南美色素失调治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太色素失调治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲色素障碍治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Affiliated Dermatology
  • Allergan, Inc.
  • Derma Med Spa
  • EpiPharm AG
  • GK Dermatology, PC
  • Kaya Limited
  • La Roche-Posay by L'Oreal Singapore Pte. Ltd.
  • Obagi Cosmeceuticals LLC
  • Skin Deep Laser Services
  • VIVIER PHARMA USA
  • Water's Edge Dermatology
Product Code: MRR-030EE4851634

The Pigmentation Disorders Treatment Market was valued at USD 6.78 billion in 2023, expected to reach USD 7.28 billion in 2024, and is projected to grow at a CAGR of 7.42%, to USD 11.21 billion by 2030.

The Pigmentation Disorders Treatment market encompasses therapies and solutions aimed at correcting abnormalities in skin coloration caused by factors such as melanin overproduction, hormonal imbalances, or genetic conditions. This market holds significant necessity due to the growing demand for aesthetically pleasing skin and the increasing prevalence of pigmentation disorders like melasma, vitiligo, and hyperpigmentation. Applications include topical ointments, laser therapies, chemical peels, and pharmaceutical interventions primarily used by dermatologists and cosmetic clinics. The end-use scope extends to both medical facilities and direct consumer skincare brands focused on beauty and wellness.

KEY MARKET STATISTICS
Base Year [2023] USD 6.78 billion
Estimated Year [2024] USD 7.28 billion
Forecast Year [2030] USD 11.21 billion
CAGR (%) 7.42%

Market growth is bolstered by advancements in dermatological technology and increasing consumer awareness about skin health. Rising disposable incomes in emerging economies and a trend towards self-care are leading to greater adoption rates of treatment options. Moreover, the development of more effective, less invasive treatments offers substantial opportunities for market expansion. However, limitations such as the high cost of advanced treatments, a lack of universal insurance coverage, and the potential for side effects pose challenges. Further, the market is fragmented with regional variances in product availability and patient access to treatments.

To capitalize on growth opportunities, businesses should invest in next-generation therapies that minimize side effects and offer faster results, such as gene therapy and bioengineered skin treatments. Enhancing research into personalized and ethnically-tailored treatment regimens can also drive market leadership. The nature of this market is competitive, characterized by continuous innovation, regulatory scrutiny, and a fast pace of technological advancements. Effective market strategies should focus on strategic partnerships, mergers, and acquisitions to bolster research and development capabilities. Innovative marketing targeting younger demographics and leveraging digital health platforms could also enhance consumer engagement and broaden market reach.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pigmentation Disorders Treatment Market

The Pigmentation Disorders Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising awareness and concerns about importance of skincare
    • Growing expenditure on cosmetics and skincare products
    • Rising R&D spending and aggressive marketing strategies
  • Market Restraints
    • High cost of treatments and varying output results
  • Market Opportunities
    • Technological advancements like laser treatment and needling process
    • Advancements in various drugs like azelaic acid
  • Market Challenges
    • Increasing skin sensitivity, allergies and reactions to some

Porter's Five Forces: A Strategic Tool for Navigating the Pigmentation Disorders Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pigmentation Disorders Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pigmentation Disorders Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pigmentation Disorders Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pigmentation Disorders Treatment Market

A detailed market share analysis in the Pigmentation Disorders Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pigmentation Disorders Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pigmentation Disorders Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pigmentation Disorders Treatment Market

A strategic analysis of the Pigmentation Disorders Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pigmentation Disorders Treatment Market, highlighting leading vendors and their innovative profiles. These include Affiliated Dermatology, Allergan, Inc., Derma Med Spa, EpiPharm AG, GK Dermatology, PC, Kaya Limited, La Roche-Posay by L'Oreal Singapore Pte. Ltd., Obagi Cosmeceuticals LLC, Skin Deep Laser Services, VIVIER PHARMA USA, and Water's Edge Dermatology.

Market Segmentation & Coverage

This research report categorizes the Pigmentation Disorders Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Hyperpigmentation and Hypopigmentation.
  • Based on Treatment & Therapies, market is studied across Chemical Peels, Dermabrasion, Laser Resurfacing, and Melasma.
  • Based on End User, market is studied across Dermatology Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising awareness and concerns about importance of skincare
      • 5.1.1.2. Growing expenditure on cosmetics and skincare products
      • 5.1.1.3. Rising R&D spending and aggressive marketing strategies
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of treatments and varying output results
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements like laser treatment and needling process
      • 5.1.3.2. Advancements in various drugs like azelaic acid
    • 5.1.4. Challenges
      • 5.1.4.1. Increasing skin sensitivity, allergies and reactions to some
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pigmentation Disorders Treatment Market, by Indication

  • 6.1. Introduction
  • 6.2. Hyperpigmentation
  • 6.3. Hypopigmentation

7. Pigmentation Disorders Treatment Market, by Treatment & Therapies

  • 7.1. Introduction
  • 7.2. Chemical Peels
  • 7.3. Dermabrasion
  • 7.4. Laser Resurfacing
  • 7.5. Melasma

8. Pigmentation Disorders Treatment Market, by End User

  • 8.1. Introduction
  • 8.2. Dermatology Clinics
  • 8.3. Hospitals

9. Americas Pigmentation Disorders Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Pigmentation Disorders Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Pigmentation Disorders Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Affiliated Dermatology
  • 2. Allergan, Inc.
  • 3. Derma Med Spa
  • 4. EpiPharm AG
  • 5. GK Dermatology, PC
  • 6. Kaya Limited
  • 7. La Roche-Posay by L'Oreal Singapore Pte. Ltd.
  • 8. Obagi Cosmeceuticals LLC
  • 9. Skin Deep Laser Services
  • 10. VIVIER PHARMA USA
  • 11. Water's Edge Dermatology

LIST OF FIGURES

  • FIGURE 1. PIGMENTATION DISORDERS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. PIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. PIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PIGMENTATION DISORDERS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PIGMENTATION DISORDERS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HYPERPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HYPOPIGMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CHEMICAL PEELS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMABRASION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER RESURFACING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MELASMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT & THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM PIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. PIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. PIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023